Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bio-Path Holdings (BPTH)

Bio-Path Holdings (BPTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,998
  • Shares Outstanding, K 2,080
  • Annual Sales, $ 0 K
  • Annual Income, $ -16,080 K
  • 60-Month Beta 0.23
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.69
Trade BPTH with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -12.44
  • Most Recent Earnings $-1.16 on 08/15/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate -1.02
  • Number of Estimates 1
  • High Estimate -1.02
  • Low Estimate -1.02
  • Prior Year -6.40
  • Growth Rate Est. (year over year) +84.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.8820 +2.04%
on 09/20/24
1.8700 -51.87%
on 08/21/24
-0.5795 (-39.17%)
since 08/20/24
3-Month
0.8820 +2.04%
on 09/20/24
2.3999 -62.50%
on 06/21/24
-1.4000 (-60.87%)
since 06/20/24
52-Week
0.8820 +2.04%
on 09/20/24
21.6000 -95.83%
on 10/13/23
-7.2800 (-89.00%)
since 09/20/23

Most Recent Stories

More News
Bio-Path: Q2 Earnings Snapshot

Bio-Path: Q2 Earnings Snapshot

BPTH : 0.9242 (-3.80%)
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase

EQNX::TICKER_START (NYSE:ATNM),(NASDAQ:BPTH),(NASDAQ:LGVN),(NASDAQ:SLS),(NYSE:BMY) EQNX::TICKER_END

ATNM : 1.8800 (+0.53%)
BPTH : 0.9242 (-3.80%)
LGVN : 2.06 (unch)
SLS : 1.2300 (+0.82%)
BMY : 49.40 (+0.78%)
Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increase

ATNM : 1.8800 (+0.53%)
BPTH : 0.9242 (-3.80%)
LGVN : 2.06 (unch)
SLS : 1.2300 (+0.82%)
BMY : 49.40 (+0.78%)
Bio-Path: Q1 Earnings Snapshot

Bio-Path: Q1 Earnings Snapshot

BPTH : 0.9242 (-3.80%)
Bio-Path: Q3 Earnings Snapshot

Bio-Path: Q3 Earnings Snapshot

BPTH : 0.9242 (-3.80%)
Bio-Path: Q2 Earnings Snapshot

Bio-Path: Q2 Earnings Snapshot

BPTH : 0.9242 (-3.80%)
Bio-Path: Q1 Earnings Snapshot

Bio-Path: Q1 Earnings Snapshot

BPTH : 0.9242 (-3.80%)
Bio-Path: Q3 Earnings Snapshot

Bio-Path: Q3 Earnings Snapshot

BPTH : 0.9242 (-3.80%)
Bio-Path Holdings to Announce Second Quarter 2022 Financial Results on August 16, 2022

HOUSTON, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize®...

BPTH : 0.9242 (-3.80%)
Bio-Path Holdings Reports First Quarter 2022 Financial Results

Conference Call to be Held Today at 8:30 A.M. ET...

BPTH : 0.9242 (-3.80%)

Business Summary

BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout...

See More

Key Turning Points

3rd Resistance Point 1.0597
2nd Resistance Point 1.0398
1st Resistance Point 1.0003
Last Price 0.9242
1st Support Level 0.9409
2nd Support Level 0.9210
3rd Support Level 0.8815

See More

52-Week High 21.6000
Fibonacci 61.8% 13.6857
Fibonacci 50% 11.2410
Fibonacci 38.2% 8.7963
Last Price 0.9242
52-Week Low 0.8820

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar